In mid-2022, 118 drugs were on the FDA’s list.
New additions and updates to the database include cisplatin, a drug used for multiple cancers; atropine sulfate injection, which blocks severe muscarinic effects; and lidocaine hydrochloride oral topical solutions, a local anesthetic.
After months of worsening shortages for cisplatin and other cancer therapies, the FDA allowed a China-based drug company to produce and import cisplatin, and the American Society of Clinical Oncology and the Society of Gynecologic Oncology recommended reserving supply for some patients.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
